Literature DB >> 33247282

Nondestructive production of exosomes loaded with ultrathin palladium nanosheets for targeted bio-orthogonal catalysis.

Victor Sebastian1,2,3, María Sancho-Albero4,5,6, Manuel Arruebo4,5,6, Ana M Pérez-López7,8, Belén Rubio-Ruiz7,9, Pilar Martin-Duque6,10, Asier Unciti-Broceta7, Jesús Santamaría4,5,6.   

Abstract

The use of exosomes as selective delivery vehicles of therapeutic agents, such as drugs or hyperthermia-capable nanoparticles, is being intensely investigated on account of their preferential tropism toward their parental cells. However, the methods used to introduce a therapeutic load inside exosomes often involve disruption of their membrane, which may jeopardize their targeting capabilities, attributed to their surface integrins. On the other hand, in recent years bio-orthogonal catalysis has emerged as a new tool with a myriad of potential applications in medicine. These bio-orthogonal processes, often based on Pd-catalyzed chemistry, would benefit from systems capable of delivering the catalyst to target cells. It is therefore highly attractive to combine the targeting capabilities of exosomes and the bio-orthogonal potential of Pd nanoparticles to create new therapeutic vectors. In this protocol, we provide detailed information on an efficient procedure to achieve a high load of catalytically active Pd nanosheets inside exosomes, without disrupting their membranes. The protocol involves a multistage process in which exosomes are first harvested, subjected to impregnation with a Pd salt precursor followed by a mild reduction process using gas-phase CO, which acts as both a reducing and growth-directing agent to produce the desired nanosheets. The technology is scalable, and the protocol can be conducted by any researcher having basic biology and chemistry skills in ~3 d.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33247282     DOI: 10.1038/s41596-020-00406-z

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  44 in total

1.  Palladium-triggered deprotection chemistry for protein activation in living cells.

Authors:  Jie Li; Juntao Yu; Jingyi Zhao; Jie Wang; Siqi Zheng; Shixian Lin; Long Chen; Maiyun Yang; Shang Jia; Xiaoyu Zhang; Peng R Chen
Journal:  Nat Chem       Date:  2014-03-16       Impact factor: 24.427

2.  A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells.

Authors:  M Lieber; B Smith; A Szakal; W Nelson-Rees; G Todaro
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

3.  Palladium-mediated intracellular chemistry.

Authors:  Rahimi M Yusop; Asier Unciti-Broceta; Emma M V Johansson; Rosario M Sánchez-Martín; Mark Bradley
Journal:  Nat Chem       Date:  2011-02-06       Impact factor: 24.427

4.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

5.  Long Term Culture of the A549 Cancer Cell Line Promotes Multilamellar Body Formation and Differentiation towards an Alveolar Type II Pneumocyte Phenotype.

Authors:  James Ross Cooper; Muhammad Bilal Abdullatif; Edward C Burnett; Karen E Kempsell; Franco Conforti; Howard Tolley; Jane E Collins; Donna E Davies
Journal:  PLoS One       Date:  2016-10-28       Impact factor: 3.240

Review 6.  Engineering exosomes as refined biological nanoplatforms for drug delivery.

Authors:  Xin Luan; Kanokwan Sansanaphongpricha; Ila Myers; Hongwei Chen; Hebao Yuan; Duxin Sun
Journal:  Acta Pharmacol Sin       Date:  2017-04-10       Impact factor: 6.150

Review 7.  The Future of Bioorthogonal Chemistry.

Authors:  Neal K Devaraj
Journal:  ACS Cent Sci       Date:  2018-07-23       Impact factor: 14.553

8.  Bioorthogonal chemistry: fishing for selectivity in a sea of functionality.

Authors:  Ellen M Sletten; Carolyn R Bertozzi
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

9.  Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach.

Authors:  Jason T Weiss; John C Dawson; Kenneth G Macleod; Witold Rybski; Craig Fraser; Carmen Torres-Sánchez; E Elizabeth Patton; Mark Bradley; Neil O Carragher; Asier Unciti-Broceta
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

10.  Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.

Authors:  Jason T Weiss; John C Dawson; Craig Fraser; Witold Rybski; Carmen Torres-Sánchez; Mark Bradley; E Elizabeth Patton; Neil O Carragher; Asier Unciti-Broceta
Journal:  J Med Chem       Date:  2014-06-12       Impact factor: 7.446

View more
  2 in total

1.  A DNAzyme-augmented bioorthogonal catalysis system for synergistic cancer therapy.

Authors:  Yawen You; Hao Liu; Jiawei Zhu; Yibo Wang; Fang Pu; Jinsong Ren; Xiaogang Qu
Journal:  Chem Sci       Date:  2022-06-10       Impact factor: 9.969

Review 2.  Tango of dual nanoparticles: Interplays between exosomes and nanomedicine.

Authors:  Yabin Wang; Wenzhen Wang; Fangong Kong; Qiu Zhang; Jiaqi Xiao; Yi Zhang; Bing Yan
Journal:  Bioeng Transl Med       Date:  2021-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.